168 related articles for article (PubMed ID: 36580755)
61. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
[TBL] [Abstract][Full Text] [Related]
62. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
[TBL] [Abstract][Full Text] [Related]
63. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
[TBL] [Abstract][Full Text] [Related]
64. FIGO stage IIIC endometrial cancer identification among patients with complex atypical hyperplasia, grade 1 and 2 endometrioid endometrial cancer: laparoscopic indocyanine green sentinel lymph node mapping versus frozen section of the uterus, why get around the problem?
Papadia A; Gasparri ML; Siegenthaler F; Imboden S; Mohr S; Mueller MD
J Cancer Res Clin Oncol; 2017 Mar; 143(3):491-497. PubMed ID: 27834005
[TBL] [Abstract][Full Text] [Related]
65. Optimizing the treatment algorithm for sentinel lymph node mapping in endometrial cancer.
Pijnenborg JMA; Reijnen C; Vergeldt TFM; Zusterzeel PLM
Semin Oncol; 2020; 47(2-3):138-143. PubMed ID: 32513418
[TBL] [Abstract][Full Text] [Related]
66. Laparoendoscopic Single-Site Sentinel Lymph Node Detection in Endometrial Cancer.
Demirayak G; Comba C; Özdemir İA
J Minim Invasive Gynecol; 2018; 25(5):776. PubMed ID: 29146390
[TBL] [Abstract][Full Text] [Related]
67. Advances in management of nonendometrioid endometrial carcinoma, with an emphasis on the sentinel lymph node technique.
Eriksson AGZ; Mueller JJ
Curr Opin Oncol; 2021 Sep; 33(5):457-463. PubMed ID: 34264897
[TBL] [Abstract][Full Text] [Related]
68. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges.
Stewart KI; Eska JS; Harrison RF; Suidan R; Abraham A; Chisholm GB; Meyer LA; Westin SN; Fleming ND; Frumovitz M; Aloia TA; Soliman PT
Int J Gynecol Cancer; 2020 Mar; 30(3):352-357. PubMed ID: 31911539
[TBL] [Abstract][Full Text] [Related]
69. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
[TBL] [Abstract][Full Text] [Related]
70. Comparison of sentinel lymph node distribution and lymphatic drainage pathway between high- and low-risk endometrial cancers.
Chen J; Liang S; He M; Wang Z; Deng H; Zhang G; Yang X; Liang X; Sun X; Zhou R; Li X; Li Y; Wang J
Arch Gynecol Obstet; 2023 Nov; 308(5):1641-1647. PubMed ID: 37430177
[TBL] [Abstract][Full Text] [Related]
71. Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.
Tanner E; Puechl A; Levinson K; Havrilesky LJ; Sinno A; Secord AA; Fader AN; Lee PS
Gynecol Oncol; 2017 Dec; 147(3):535-540. PubMed ID: 29056441
[TBL] [Abstract][Full Text] [Related]
72. Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer.
Dioun S; Chen L; Melamed A; Gockley A; St Clair CM; Hou JY; Khoury-Collado F; Hershman DL; Wright JD
BJOG; 2022 Aug; 129(9):1591-1599. PubMed ID: 34962708
[TBL] [Abstract][Full Text] [Related]
73. Uptake in sentinel lymph node biopsy for endometrial cancer with T3 classification.
Matsuo K; Klar M; Khetan VU; Vallejo A; Violette CJ; Tavakoli A; Nusbaum DJ; Roman LD; Wright JD
Gynecol Oncol; 2022 May; 165(2):361-368. PubMed ID: 35272876
[TBL] [Abstract][Full Text] [Related]
74. Precise lymph node biopsy for endometrial cancer confined to the uterus: Analysis of 43 clinical cases.
Shi XL; Chen S; Guo GD; Yang YL; Tong KM; Cao W; Huang LL; Zhang YR
Taiwan J Obstet Gynecol; 2024 May; 63(3):369-374. PubMed ID: 38802200
[TBL] [Abstract][Full Text] [Related]
75. Impact of Sentinel Node Mapping in Decreasing the Risk of Lymphocele in Endometrial Cancer.
Diniz TP; Drizlionoks E; Faloppa CC; Menezes JN; Mantoan H; Gonçalves BT; Brandao PHDM; Kumagai LY; Badiglian-Filho L; da Costa AABA; Baiocchi G
Ann Surg Oncol; 2021 Jun; 28(6):3293-3299. PubMed ID: 33108597
[TBL] [Abstract][Full Text] [Related]
76. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.
Cusimano MC; Vicus D; Pulman K; Maganti M; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Hogen LF; Covens AL; Gien LT; Kupets R; Rouzbahman M; Clarke BA; Mirkovic J; Cesari M; Turashvili G; Zia A; Ene GEV; Ferguson SE
JAMA Surg; 2021 Feb; 156(2):157-164. PubMed ID: 33175109
[TBL] [Abstract][Full Text] [Related]
77. Sentinel Node Mapping Using Indocyanine Green and Near-infrared Fluorescence Imaging Technology for Uterine Malignancies: Preliminary Experience With the Da Vinci Xi System.
Siesto G; Romano F; Fiamengo B; Vitobello D
J Minim Invasive Gynecol; 2016; 23(4):470-1. PubMed ID: 26767824
[TBL] [Abstract][Full Text] [Related]
78. Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.
Kim SR; Tone A; Kim RH; Cesari M; Clarke BA; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Lajkosz K; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh T; Pollett A; Ferguson SE
Gynecol Oncol; 2021 Apr; 161(1):221-227. PubMed ID: 33478752
[TBL] [Abstract][Full Text] [Related]
79. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
[TBL] [Abstract][Full Text] [Related]
80. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
